These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19967487)

  • 1. Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients.
    Tamiya A; Yamazaki K; Boku N; Machida N; Kojima T; Taku K; Yasui H; Fukutomi A; Hironaka S; Onozawa Y
    Int J Clin Oncol; 2009 Dec; 14(6):513-7. PubMed ID: 19967487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.
    Sogabe S; Komatsu Y; Yuki S; Kusumi T; Hatanaka K; Nakamura M; Kato T; Miyagishima T; Hosokawa A; Iwanaga I; Sakata Y; Asaka M
    Jpn J Clin Oncol; 2011 Apr; 41(4):490-7. PubMed ID: 21303790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of chemotherapy combined with bevacizumab for metastatic colorectal cancer].
    Momoi A; Motomura S; Hashimoto C; Takasaki H; Takemura S; Takagi S; Akaike M
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):79-83. PubMed ID: 21368462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
    Kozloff M; Yood MU; Berlin J; Flynn PJ; Kabbinavar FF; Purdie DM; Ashby MA; Dong W; Sugrue MM; Grothey A;
    Oncologist; 2009 Sep; 14(9):862-70. PubMed ID: 19726453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis.
    Kang BW; Kim TW; Lee JL; Ryu MH; Chang HM; Yu CS; Kim JC; Kim JH; Kang YK; Lee JS
    Med Oncol; 2009; 26(1):32-7. PubMed ID: 18498064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding after bevacizumab treatment in patients with metastatic colorectal cancer.
    Cao D; Guo CH; Liu JW; Yang X; Li Q
    Tumori; 2015; 101(1):46-51. PubMed ID: 25702674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer.
    Cao Y; Tan A; Gao F; Liu L; Liao C; Mo Z
    Int J Colorectal Dis; 2009 Jun; 24(6):677-85. PubMed ID: 19184059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab safety in Japanese patients with colorectal cancer.
    Hatake K; Doi T; Uetake H; Takahashi Y; Ishihara Y; Shirao K
    Jpn J Clin Oncol; 2016 Mar; 46(3):234-40. PubMed ID: 26774113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.
    Chen HX; Mooney M; Boron M; Vena D; Mosby K; Grochow L; Jaffe C; Rubinstein L; Zwiebel J; Kaplan RS
    J Clin Oncol; 2006 Jul; 24(21):3354-60. PubMed ID: 16849749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis on the efficacy of bevacizumab with FOLFOX as a first-line treatment in Japanese patients with metastatic colorectal cancer.
    Suenaga M; Mizunuma N; Matsusaka S; Shinozaki E; Ueno M; Yamaguchi T
    Asia Pac J Clin Oncol; 2014 Dec; 10(4):322-9. PubMed ID: 23915091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.
    Crinò L; Dansin E; Garrido P; Griesinger F; Laskin J; Pavlakis N; Stroiakovski D; Thatcher N; Tsai CM; Wu YL; Zhou C
    Lancet Oncol; 2010 Aug; 11(8):733-40. PubMed ID: 20650686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bevacizumab in combination with mFOLFOX6 or FOLFIRI for previously treated metastatic colorectal cancer].
    Koyama M; Murata A; Kimura Y; Sakamoto Y; Morohashi H; Kimura N; Gasa F; Sato J; Terui K; Awatsu A; Hakamada K
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1069-73. PubMed ID: 20567110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing patients with metastatic colorectal cancer on bevacizumab.
    Lemmens L; Claes V; Uzzell M
    Br J Nurs; 2008 Aug 14-Sep 10; 17(15):944-9. PubMed ID: 18983014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients.
    Saito S; Hayashi N; Sato N; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Watanabe M; Yoshida M; Sakai K; Katsumori T; Katahuchi S; Shigaki N; Yamada K; Kimura M; Tanigawa T; Takano S; Kuramoto M; Baba H
    Int J Clin Oncol; 2013 Aug; 18(4):689-95. PubMed ID: 22664951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing patients treated with bevacizumab combination therapy.
    Gordon MS; Cunningham D
    Oncology; 2005; 69 Suppl 3():25-33. PubMed ID: 16301833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.
    Hompes D; Ruers T
    Eur J Surg Oncol; 2011 Sep; 37(9):737-46. PubMed ID: 21764243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.
    Isobe T; Uchino K; Makiyama C; Ariyama H; Arita S; Tamura S; Komoda M; Kusaba H; Shirakawa T; Esaki T; Mitsugi K; Takaishi S; Akashi K; Baba E
    Anticancer Res; 2014 Apr; 34(4):2035-40. PubMed ID: 24692744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy.
    Österlund P; Soveri LM; Isoniemi H; Poussa T; Alanko T; Bono P
    Br J Cancer; 2011 Feb; 104(4):599-604. PubMed ID: 21304526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
    Kozloff MF; Berlin J; Flynn PJ; Kabbinavar F; Ashby M; Dong W; Sing AP; Grothey A
    Oncology; 2010; 78(5-6):329-39. PubMed ID: 20733336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
    Hurwitz HI; Fehrenbacher L; Hainsworth JD; Heim W; Berlin J; Holmgren E; Hambleton J; Novotny WF; Kabbinavar F
    J Clin Oncol; 2005 May; 23(15):3502-8. PubMed ID: 15908660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.